Invasive micropapillary carcinoma of the male breast: Case report and review of the literature

J.T. Stranix , M.J. Kwa , R.L. Shapiro , J.L. Speyer
{"title":"Invasive micropapillary carcinoma of the male breast: Case report and review of the literature","authors":"J.T. Stranix ,&nbsp;M.J. Kwa ,&nbsp;R.L. Shapiro ,&nbsp;J.L. Speyer","doi":"10.1016/j.ctrc.2014.12.001","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>Invasive micropapillary carcinoma (IMPC) of the breast is a rare and aggressive variant of invasive ductal carcinoma. IMPC has been reported to account for 3–6% of all breast cancers, and these tumors have been associated with a strong tendency to invade lymphatics with early spread to regional lymph nodes.</p></div><div><h3>Patients and methods</h3><p>We present a case of this rare type of breast cancer diagnosed in a male patient and summarize the current literature to date.</p></div><div><h3>Results</h3><p>Review of the literature on invasive micropapillary breast carcinoma revealed 27 retrospective cohort studies and case series. Significant heterogeneity of inclusion criteria and follow up data prevented meta-analysis. Tumors with an IMPC component demonstrated an early and high rate of lymphatic metastasis compared to invasive ductal carcinoma, however, no significant association was found between IMPC and decreased overall survival.</p></div><div><h3>Conclusions</h3><p>The IMPC data currently available indicates a strong trend towards a higher initial stage at diagnosis and possibly an increased risk of loco-regional recurrence, but remains underpowered to elucidate the prognostic effect of IMPC phenotype on survival. Further studies are warranted to establish the potential of this unique histologic phenotype to serve as a prognostic indicator and guide tumor-specific oncologic therapy.</p></div>","PeriodicalId":90461,"journal":{"name":"Cancer treatment communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ctrc.2014.12.001","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2213089614000152","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Background

Invasive micropapillary carcinoma (IMPC) of the breast is a rare and aggressive variant of invasive ductal carcinoma. IMPC has been reported to account for 3–6% of all breast cancers, and these tumors have been associated with a strong tendency to invade lymphatics with early spread to regional lymph nodes.

Patients and methods

We present a case of this rare type of breast cancer diagnosed in a male patient and summarize the current literature to date.

Results

Review of the literature on invasive micropapillary breast carcinoma revealed 27 retrospective cohort studies and case series. Significant heterogeneity of inclusion criteria and follow up data prevented meta-analysis. Tumors with an IMPC component demonstrated an early and high rate of lymphatic metastasis compared to invasive ductal carcinoma, however, no significant association was found between IMPC and decreased overall survival.

Conclusions

The IMPC data currently available indicates a strong trend towards a higher initial stage at diagnosis and possibly an increased risk of loco-regional recurrence, but remains underpowered to elucidate the prognostic effect of IMPC phenotype on survival. Further studies are warranted to establish the potential of this unique histologic phenotype to serve as a prognostic indicator and guide tumor-specific oncologic therapy.

男性乳腺浸润性微乳头状癌:病例报告及文献复习
背景:乳腺浸润性微乳头状癌(IMPC)是一种罕见的侵袭性导管癌。据报道,IMPC占所有乳腺癌的3-6%,这些肿瘤有很强的侵袭淋巴的倾向,早期扩散到局部淋巴结。患者和方法我们报告一例罕见的男性乳腺癌,并总结目前的文献资料。结果回顾浸润性微乳头状乳腺癌的文献,发现27项回顾性队列研究和病例系列。纳入标准和随访数据的显著异质性阻碍了meta分析。与浸润性导管癌相比,具有IMPC成分的肿瘤表现出早期和高的淋巴转移率,然而,IMPC与总生存期降低之间没有显著关联。结论:目前可用的IMPC数据表明,诊断时的初始阶段较高,可能增加局部区域复发的风险,但仍然不足以阐明IMPC表型对生存的预后影响。进一步的研究需要确定这种独特的组织学表型作为预后指标和指导肿瘤特异性肿瘤治疗的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信